| |
| |
|
| Insider
Information: |
Praill Scott |
| Relationship: |
Chief Financial Officer |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
277,273 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$23,319 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
277,273 |
|
|
| Total
Value |
$23,319 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -78.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kintara Therapeutics, Inc |
KTRA |
Chief Financial Officer |
2022-08-01 |
277,273 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
240,087 |
277,273 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2021-12-08 |
4 |
B |
$0.68 |
$19,430 |
D/D |
28,700 |
37,186 |
2.74 |
% |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
938 |
8,486 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
7,548 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,540 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,518 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,496 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2020-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,452 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,430 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,408 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2019-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,386 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2019-03-29 |
4 |
A |
$0.49 |
$103 |
D/D |
211 |
73,632 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2018-12-31 |
4 |
A |
$0.34 |
$72 |
D/D |
211 |
73,421 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2018-09-28 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
73,210 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2018-06-29 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
72,999 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2018-03-30 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
72,788 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
72,577 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-12-31 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
47,577 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-10-05 |
4 |
B |
$0.85 |
$14,910 |
D/D |
17,500 |
47,366 |
2.74 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-09-29 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
29,866 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-06-30 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
29,655 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-06-26 |
4 |
B |
$3.60 |
$15,001 |
D/D |
4,167 |
29,444 |
2.74 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-06-06 |
4 |
B |
$2.10 |
$19,950 |
D/D |
9,500 |
25,277 |
2.74 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2017-03-31 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
15,777 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Chief Financial Officer |
• – – |
2016-12-31 |
4 |
A |
$3.20 |
$675 |
D/D |
211 |
15,566 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
